Taking advantage of ApoESA/SA mice, a new model combining both hypercholesterolemia and hypertension that rapidly develops atherosclerosis (manuscript under submission), we examined the impact of RIPK1 inhibition on advanced atherosclerosis. This evidence concerns the gene RIPK1 and hypertensive disorder.